Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Apatinib Combined”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04447274
What this trial is testing

Carilizumab in Combination With Apatinib in Subjects With Unresectable UPS and ASPS

Who this might be right for
Sarcoma
Chinese Academy of Medical Sciences 20
Large-scale testing (Phase 3)Active Not RecruitingNCT06447623
What this trial is testing

Apatinib Combined With cdk4/6i in First-line Treatment for HR+/HER2- SNF4 Subtype Breast Cancer

Who this might be right for
Advanced Breast CancerHR+/HER2- Breast Cancer
Fudan University 184
Early research (Phase 1)UnknownNCT03026881
What this trial is testing

Fluzoparib Given in Combination With Apatinib and Paclitaxel in Gastric Cancer Patients

Who this might be right for
Recurrent and Metastatic Gastric Cancer
Jiangsu HengRui Medicine Co., Ltd. 24
Early research (Phase 1)UnknownNCT05001412
What this trial is testing

Chemotherapy Combined With Camrelizumab and Apatinib in First-line Treatment of ES-SCLC

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Zhou Chengzhi 36
Testing effectiveness (Phase 2)UnknownNCT04014101
What this trial is testing

SHR-1210 Plus Apatinib in Patients With Advanced-Stage Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 40
Not applicableUnknownNCT04609293
What this trial is testing

Observational Study of Camrelizumab Combined With Apatinib and Hyperfractionated Radiotherapy for Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Peking University First Hospital 30
Testing effectiveness (Phase 2)Study completedNCT03243838
What this trial is testing

Low-dose Apatinib Combined With Neoadjuvant Chemotherapy in the Treatment of Early Triple Negative Breast Cancer

Who this might be right for
Triple-Negative Breast Cancer
Guangdong Provincial People's Hospital 31
Post-approval studies (Phase 4)WithdrawnNCT03792503
What this trial is testing

Pemetrexed Plus Apatinib Maintenance Treatment in Patients With Non-squamous Non-small Cell Lung Cancer Patients Who Have Not Progressed After 4 Cycles of Induction Chemotherapy of Pemetrexed in Combination With Platinum-based Regimen

Who this might be right for
Advanced Non-squamous Non-small-cell Lung Cancer
Xinqiao Hospital of Chongqing
Testing effectiveness (Phase 2)UnknownNCT05171309
What this trial is testing

Camrelizumab in Combination With Apatinib Plus NK Cell for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Nanfang Hospital, Southern Medical University 35
Testing effectiveness (Phase 2)Study completedNCT03472365
What this trial is testing

SHR-1210 in Combination With Capecitabine + Oxaliplatin or Apatinib in Treatment of Advanced Gastric Cancer

Who this might be right for
Gastric CancerGastroEsophageal Cancer
Jiangsu HengRui Medicine Co., Ltd. 67
Testing effectiveness (Phase 2)Looking for participantsNCT06099821
What this trial is testing

KN046 Plus Regorafenib or Apatinib in MSI-H Digestive System Cancers Resistant to PD-1/PD-L1 Blockade

Who this might be right for
Digestive System Cancers
Peking University Cancer Hospital & Institute 39
Testing effectiveness (Phase 2)UnknownNCT04683198
What this trial is testing

Camrelizumab Combined With Apatinib ,Carboplatin and Etoposide in Participants With ES-SCLC

Who this might be right for
Small-cell Lung Cancer
Chinese Academy of Medical Sciences 69
Not applicableNot Yet RecruitingNCT07371871
What this trial is testing

A Prospective, Single-arm, Exploratory Study of Trifluridine/Tipiracil (TAS-102) Combined With Apatinib as Third-line Therapy for Advanced Gastric Cancer

Who this might be right for
Advanced Gastric Cancer
Anhui Provincial Cancer Hospital 30
Testing effectiveness (Phase 2)UnknownNCT03603756
What this trial is testing

SHR-1210 in Combination With Apatinib and Chemotherapy in Patients With Advanced Esophageal Squamous Cell Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
Chinese Academy of Medical Sciences 45
Testing effectiveness (Phase 2)Looking for participantsNCT06483282
What this trial is testing

Adebrelimab Combined With Apatinib Mesylate and Chemotherapy for Neoadjuvant Therapy and Biomarker Analysis in Limited-stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer Limited Stage
Jin Ying 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT04560127
What this trial is testing

Camrelizumab in Combination With Apatinib in Patients With Radioactive Iodine-refractory Differentiated Thyroid Cancer

Who this might be right for
Radioactive Iodine-refractory Differentiated Thyroid Cancer
Peking Union Medical College Hospital 20
Testing effectiveness (Phase 2)Study completedNCT04350190
What this trial is testing

Apatinib Combined With PD-1 in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Wei Jiang 25
Testing effectiveness (Phase 2)UnknownNCT04523662
What this trial is testing

Study on the Effectiveness and Safety of Carrelizumab Combined With Apatinib Mesylate and Radiotherapy in the Treatment of Advanced Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
Beijing Tsinghua Chang Gung Hospital 27
Testing effectiveness (Phase 2)UnknownNCT03389256
What this trial is testing

Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC

Who this might be right for
Lung DiseasesNeoplasmsRespiratory Tract Diseases+2 more
Sichuan Cancer Hospital and Research Institute 144
Testing effectiveness (Phase 2)UnknownNCT04297202
What this trial is testing

SHR-1210 Combined With Apatinib Mesylate in the Perioperative Treatment of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
The First Affiliated Hospital with Nanjing Medical University 20
Next Page